By a News Reporter-Staff News Editor at Managed Care Weekly Digest — Magellan Rx Management, the pharmacy benefit management (PBM) division of Magellan Health, Inc. (NASDAQ: MGLN) released its Medicaid Trend Report, developed through in-depth data analysis and supported by Magellan’s broad national experience managing the fee-for-service (FFS) Medicaid pharmacy programs for 25 states and Washington, D.C. The report, the first of its kind, examines clinically appropriate drug use and cost-savings opportunities for Medicaid FFS programs across the country (see also Magellan Health, Inc.).
“Our report takes a retrospective look at data from the FFS programs we administered from 2014 through 2015, and identifies the tools and practices that enabled state Medicaid programs to manage the increase in net cost per claim to three percent year-over-year,” said Doug Brown, a registered pharmacist and vice president of pharmacy pricing and value-based solutions. “Importantly, our report also takes a prospective look and outlines several …
Go to Source

Rx Management's Medicaid Trend Report Highlights Strategies for States to Improve Care, Lower Costs